Personal Assistant for Pharma CEO Conference Management

How a personal assistant manages medical conference logistics for pharmaceutical CEOs, including BIO, ASCO, JPMorgan, and disease-area summits.

Table of Contents

The pharmaceutical industry operates on a dense calendar of scientific, medical, and financial conferences that serve as critical touchpoints for CEOs with investors, partners, key opinion leaders, and policymakers. From the JPMorgan Healthcare Conference in January to the major oncology and cardiology meetings throughout the year, each conference represents both an opportunity and a logistical challenge. The personal assistant who manages conference participation for a pharmaceutical CEO must combine event logistics expertise with a deep understanding of how each conference fits into the company’s strategic priorities.

The Pharma Conference Landscape

To manage conference participation effectively, the PA must first understand the landscape of events that matter in the pharmaceutical world. These fall into several categories.

Financial and investor conferences are where CEOs present to the analyst and investor community, participate in one-on-one meetings with fund managers, and build relationships with the financial stakeholders who support the company’s capital structure. Key events include the JPMorgan Healthcare Conference, Goldman Sachs Global Healthcare Conference, Jefferies Healthcare Conference, and various investment bank-sponsored investor days.

Scientific and medical conferences are where clinical data is presented, key opinion leaders convene, and the medical community sets the direction of practice. For a pharmaceutical company, presenting data at ASCO, ASH, AHA, EASD, or ESMO can be a company-defining event. The CEO may not present at these scientific sessions, but they attend to meet with KOLs, monitor competitive presentations, and engage with the medical community.

Industry and biotech conferences include BIO International Convention, the largest annual gathering of the biotech industry, as well as BIOEUROPE, Biotech Showcase, and regional events. These conferences are where partnership discussions are initiated and business development activity is concentrated.

Policy and regulatory forums include events hosted by the FDA, Congressional hearings, and policy organizations such as the Brookings Institution or ISPOR where drug pricing and access issues are debated.

Pre-Conference Planning

Conference planning begins months before the event. For major conferences, the PA initiates planning six to twelve months in advance for the largest events. The planning process includes:

Registration and space reservation: Many conferences allocate meeting space, hospitality suites, or exhibit floor space to participating companies, with registration deadlines that require early action. The PA manages these registrations and ensures the company secures appropriate space for investor meetings or partner discussions.

Hotel and travel coordination: Major pharma conferences, particularly JPMorgan in San Francisco and BIO at various rotating locations, are notorious for hotel scarcity. The PA secures room blocks and individual reservations early, maintaining a waitlist strategy for premium properties.

Meeting schedule management: For investor conferences, the IR team typically manages the formal presentation slot and one-on-one meeting schedule. The PA works with IR to integrate the CEO’s conference schedule with additional meetings requested by partners, KOLs, or government affairs contacts. Building this integrated schedule requires coordinating across multiple teams and maintaining a master calendar that prevents double-booking.

Presentation preparation: When the CEO is presenting at a conference, the PA coordinates the preparation process, including ensuring that slides are prepared and reviewed by legal and IR, that the CEO has had adequate rehearsal time, and that any conference-specific formatting requirements are met.

On-Site Conference Management

During the conference itself, the PA often travels with the CEO or establishes a remote support structure that functions as if they were on-site. Conference days are typically 12 to 14 hours of back-to-back meetings, receptions, and dinners, requiring real-time schedule management throughout the day.

The PA manages:

Day-of scheduling adjustments: Conferences inevitably produce last-minute meeting requests from important investors or partners. The PA manages these requests, identifies available time slots or time to shift existing commitments, and communicates changes to all parties.

Logistics coordination: Getting the CEO from a morning panel to a meeting room in a different hotel building during a conference where traffic and crowds are significant requires real-time logistics thinking. The PA coordinates transportation, knows the fastest routes between venues, and communicates estimated arrival times to waiting parties.

Meeting preparation: Before each meeting, the PA ensures the CEO has the relevant briefing information, including the investor’s current holdings or the partner company’s pipeline status. This real-time briefing support may be delivered via secure messaging as the CEO moves between meetings.

Evening program management: Conference evenings typically involve sponsored dinners, receptions, and informal networking that are strategically important but logistically demanding. The PA manages RSVPs, confirms attendance at the right events, and coordinates transportation and timing.

Managing Competing Conference Commitments

A pharmaceutical CEO with multiple competing obligations may face situations where two important conferences overlap, requiring difficult choices about where to focus time and how to manage competing commitments. The PA helps the CEO think through these tradeoffs and manages the logistics of partially attending multiple events if that is the decision.

For major scientific conferences that the CEO cannot personally attend due to schedule conflicts, the PA may coordinate attendance by other executives, ensuring that the company is represented and that relevant intelligence is brought back to the CEO. This may involve coordinating a debrief meeting with the attending scientific or commercial executives immediately after the conference.

Data Presentation Coordination

When the company is presenting clinical trial data at a major medical conference such as ASCO or ASH, the event becomes significantly more complex. Data presentations are often the most important external communications a pharmaceutical company makes in a given year, and the coordination required extends well beyond logistics.

The PA works with the communications team, IR team, and medical affairs to coordinate the embargo protocol (clinical data presented at major conferences is often embargoed until the session), the investor communication plan, the media strategy, and the CEO’s messaging. The CEO will typically speak to analysts and investors on a conference call after the data is presented, requiring the PA to coordinate the call logistics and ensure the CEO is available immediately following the scientific session.

Post-Conference Follow-Up

After a major conference, the PA manages the follow-up process, which can involve dozens of meeting commitments, requested materials, and next-step actions. The PA sends follow-up communications on behalf of the CEO, schedules promised follow-up calls, and tracks commitments made during conference meetings.

For conferences where business development discussions were initiated, the PA coordinates follow-up scheduling with the business development team and ensures that the CEO’s interest in specific opportunities is communicated to the appropriate internal owners.

For more on how these conference responsibilities fit into the full PA role in pharma, see our guide to pharma PA duties. Our overview of the pharma CEO assistant role provides additional context on supporting pharmaceutical executives.

Conclusion

Medical and financial conference management is one of the most visible and high-stakes responsibilities of the pharmaceutical CEO’s personal assistant. Executed well, it enables the CEO to maximize the strategic value of every conference engagement. Executed poorly, it can result in missed meetings with key investors, logistical chaos that undermines the CEO’s executive presence, and lost opportunities for the company. The PA who masters conference management becomes a critical enabler of the CEO’s external engagement strategy.

For further context, explore Personal Assistant for 3PL CEO Third Party Logistics: Operational Support for a High-Volume Industry and Personal Assistant for Abrasive Manufacturer CEO.

#pharma-ceo#conference-management#personal-assistant#medical-conferences#pharmaceutical-executive

Need Help With Delegation?

Discuss your role scope, systems, and recurring delegation priorities.

Get My Free Consultation